EXHIBIT 23

INDEPENDENT AUDITORS' CONSENT


We consent to the incorporation by reference in this Form 8-K of DOR BioPharma,
Inc. (formerly Endorex Corporation) of our report dated March 9, 2001 (with
respect to Note I[2], July 31, 2001), with respect to the consolidated financial
statements of Corporate Technology Development, Inc. included in the
Registration Statement on Form S-4 of Endorex Corporation which became effective
with the Securities and Exchange Commission on October 23, 2001.





/s/ Richard A. Eisner & Company, LLP

New York, New York
December 11, 2001